By using cell surface markers, CD34 and CD38, which identified progenitor and pluripotent stem cells in bone marrow, AML-initiating cells that produced leukemia when transplanted in immunodeficient mice were observed to be CD34+CD38− cells. This evidence concerns the gene CD34 and leukemia.